UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
December 29, 2023
Accession Number:
0001193125-23-303584
Submission Type:
POS AM
CIK:
0001811764
Company Name:
POINT Biopharma Global Inc.
File Number:
333-265981